Our Providers

Cardihab  is committed to improving  access to Cardiac Rehabilitation for patients with Cardiovascular Disease.

See our current providers below and their contact details and eligibility information.

MPHT

MATER PRIVATE HOSPITAL TOWNSVILLE

Email:
alliedhealthadmin@mater.org.au

or call 07 4727 4650
(Mon to Fri, 8am to 4pm AEST)

FOR PATIENTS AND REFERRERS
Click here for further information

MEDIBANK

Email:
HeartHealthatHome@medibank.com.au

or call 1300 307 440
(Mon to Fri, 9am to 4pm AEST)

FOR PATIENTS AND REFERRERS
Click here for further information

NIB | Honeysuckle Health

Email:
health.facilitation@nib.com.au

or call 1800 339219
(Mon to Fri, 9am to 5pm AEST)

FOR PATIENTS AND REFERRERS
Click here for further information

QUEENSLAND CARDIOVASCULAR GROUP

Email:
info@qcg.com.au

or call 07 3016 1111
(Mon to Fri, 8am to 4pm AEST)

FOR PATIENTS AND REFERRERS
Click here for further information

QUEENSLAND COUNTRY HEALTH

Email:
carenavigation@queenslandcountry.health
or call 1300 848 034
(Mon to Fri, 8.30am to 5pm AEST)

FOR PATIENTS AND REFERRERS
Click here for further information

WA PRIMARY HEALTH ALLIANCE

Email:
WACHS-swphcampusadmin@health.wa.gov.au

Referral Form
or call 0437 603 452
(Mon to Fri, 9am to 4pm WST)

FOR PATIENTS AND REFERRERS
Click here for further information

Our Research

Cardihab is proud to collaborate with leading research partners on clinical trials and projects that help define future healthcare needs, and improve patient outcomes.

If you would be interested in learning more or participating in a clinical trial please refer to the information below, or contact info@cardihab.com

PERCEIVE

The persistent cardiovascular effects of COVID-19 viral infection study.

Click here for more information on the PERCEIVE (Covid Heart) study.

REDEEM

This study aims to understand whether the treatment of cancer (chemotherapy) causes damage to the heart.

Click here for further information on the REDEEM study.

 

RISK GUIDED CAD

Disease management in coronary artery disease.

Click here for further information on the RISK GUIDED CAD study.